BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Company Screener
Meeting Calendar
Hedge Funds
Analysts & Portfolios

My WatchlistsMy Notes
Try Pro FreeAlready have an account? Login

Enterprise Value

4.30M

Cash

63.64M

Avg Qtr Burn

-16.13M

Short % of Float

8.84%

Insider Ownership

9.34%

Institutional Own.

25.26%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
EYSUVIS™ (loteprednol etabonate ophthalmic suspension) Details
Dry Eye Disease

Approved

Quarterly sales

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INVELTYS™ (loteprednol etabonate ophthalmic suspension) Details
Post-operative ocular inflammation and pain

Approved

Quarterly sales

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KPI-012 Details
Persistent Corneal Epithelial Defect

Phase 2b

Data readout

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.